The cluster is modest in dollar terms relative to CABA's $214M market cap. The absence of insider buying weakens conviction. Monitor upcoming clinical catalysts (RESET-Myositis topline in 2H27) for potential re-rating.
How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK AT ENTRY AT T+1- T+0 · Nov 10 $1.45entry
- T+1 · 6d ago 0.00%α −1.32% · $1.45
- T+4 · todayOpen
- T+5 · in 4h Pending
- T+20 · in 22d Pending
- T+60 · in 3mo Pending
How similar events traded
Executive Summary
Nine institutional investors increased their CABA positions in Q3 2026, with three doubling their stakes, while only two trimmed. The cluster is dominated by asset managers, not passive funds, and follows the company's Q3 earnings report showing a strong cash position and clear clinical milestones. However, the 13F data is 45+ days stale, and there is no insider buying to corroborate the signal.
Key Financial Metrics
Institutional Positions
Net institutional flow: $276.0K
▲ Buyers (9)
| Institution | Action | Change | Position Value | Value Δ |
|---|---|---|---|---|
| Us Bancorp | DOUBLED | +1555.9% | $524.0K | $473.0K |
| Barclays | DOUBLED | +648.2% | $642.0K | $503.0K |
| Nisa Investment Advisors | DOUBLED | +3976.6% | $63.0K | $61.0K |
▼ Sellers (2)
| Institution | Action | Change | Prev Value | Value Δ |
|---|---|---|---|---|
| Citigroup | TRIM | -46.8% | $573.0K | -$385.0K |
| Pnc Financial Services Group | TRIM | -74.7% | $14.0K | -$12.0K |
Key Facts
- 9 institutional buyers vs 2 sellers in Q3 2026
- Three funds doubled their positions: US Bancorp (+1556%), Barclays (+648%), Nisa Investment Advisors (+3977%)
- Total buying value $2.6M, net change +$673K; total selling value -$397K
- No open-market insider buying in the same window (confluence score 30/100, 'institutions only')
- Cluster follows Q3 2026 earnings (8-K filed Nov 5) showing $299.4M cash, runway into Q1 2028
Financial Impact
9 institutions accumulated $2.6M in new positions while 2 reduced holdings by $397K; net institutional inflow of approximately $276K
Risk Factors
- 13F data is 45+ days stale; positions may have been unwound since quarter-end
- No insider buying to corroborate the institutional signal
- Dollar amounts are small relative to market cap, limiting signal strength
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 institutional 13F filing from SEC EDGAR.
| Document | Accession Number |
|---|---|
| INST-CLUSTER Data (Synthetic) | inst-cluster-CABA-2026-Q3 |
Track record
29 reports on CABA
4 of 9 bullish or bearish reports moved the stock their way by T+5. Best: +31.59% at T+60 after the May 4, 2026 report. 5 of 9 went positive at some point.
Filters
- Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $1.15 settles Nov 23
- Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $1.32 settles Nov 23
- Nov 12, 20264d ago SC 13G/A Neutral 2/10 Entry $1.33 settles Nov 19
- Nov 9, 20267d ago Institutional Cluster Neutral 3/10 Viewing Entry $1.45 settles Nov 17
- Nov 9, 20267d ago 8-K Bullish 6/10 Entry $1.50 to $1.11 ▼ −26.00% −24.31% vs SPY
- Nov 8, 20268d ago Press Release Bullish 6/10 Entry $1.50 to $1.11 ▼ −26.00% −24.31% vs SPY
- Nov 6, 202610d ago SC 13G/A Neutral 2/10 Entry $1.30 to $1.28 ▼ −1.54% −4.13% vs SPY
- Nov 6, 202610d ago SC 13G/A Neutral 2/10 Entry $1.30 to $1.28 ▼ −1.54% −4.13% vs SPY
- Nov 5, 202611d ago 8-K Neutral 4/10 Entry $1.28 to $1.33 ▲ +3.91% +0.62% vs SPY
- Nov 5, 202611d ago Press Release Neutral 4/10 No price data
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers